AstraZeneca Acquires Neogene, Expanding in Cancer Cell Therapy
November 30, 2022, 2:00 pm
AstraZeneca is acquiring Neogene Therapeutics for up to $320 million cash, bolstering its portfolio of cancer-fighting cell therapies.
Curated, Global, Hometown News for the City and Citizens of Santa Monica California
AstraZeneca Acquires Neogene, Expanding in Cancer Cell Therapy
COPYRIGHT © Indian Hill Media Inc. Another Smiling Dog Web Development. Hosted by InlandEmpire.IO ALL RIGHTS RESERVED.
COPYRIGHT © Indian Hill Media Inc. Another Smiling Dow Web Development. Hosted by InlandEmpire.IO ALL RIGHTS RESERVED.
